VYNE Therapeutics, Inc. (VYNE)
0.404
+0.03
(+7.22%)
USD |
NASDAQ |
Dec 10, 16:00
0.4003
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Free Cash Flow: -38.48M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Theravance Biopharma, Inc. | 243.48M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.096M |
| Cash from Investing (Quarterly) | 4.402M |
| Cash from Financing (Quarterly) | -0.007M |
| Free Cash Flow Per Share (Quarterly) | -0.1658 |
| Free Cash Flow to Equity (Quarterly) | -7.071M |
| Free Cash Flow to Firm (Quarterly) | -7.096M |
| Free Cash Flow Yield | -223.0% |